Arctic Bioscience AS (OSL:ABS) Other Current Liabilities : kr12.68 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS Other Current Liabilities?

Arctic Bioscience AS's other current liabilities for the quarter that ended in Dec. 2024 was kr12.68 Mil.

Arctic Bioscience AS's quarterly other current liabilities increased from Dec. 2023 (kr13.10 Mil) to Jun. 2024 (kr14.25 Mil) but then declined from Jun. 2024 (kr14.25 Mil) to Dec. 2024 (kr12.68 Mil).

Arctic Bioscience AS's annual other current liabilities declined from Dec. 2022 (kr17.62 Mil) to Dec. 2023 (kr13.10 Mil) and declined from Dec. 2023 (kr13.10 Mil) to Dec. 2024 (kr12.68 Mil).

Arctic Bioscience AS Other Current Liabilities Historical Data

The historical data trend for Arctic Bioscience AS's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arctic Bioscience AS Other Current Liabilities Chart

Arctic Bioscience AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Liabilities

Get a 7-Day Free Trial

7.06

7.13

17.62

13.10

12.68

Arctic Bioscience AS Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Current Liabilities	Get a 7-Day Free Trial							17.62	19.54	13.10	14.25	12.68

Arctic Bioscience AS Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Arctic Bioscience AS Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Arctic Bioscience AS's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Arctic Bioscience AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

9TD:Germany

Address

Industrivegen 42, Orsta, NOR, 6155

Website

https://www.arctic-bioscience.com

Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. The company is developing a novel, oral drug candidate (HRO350) for the treatment of mild-to-moderate psoriasis. The company operates geographically in Norway, Americas, Europe, and APAC, with majority of the revenue deriving from Europe.

Arctic Bioscience AS Headlines

No Headlines